Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphatidylinositol transfer protein beta (PITPNB) is a monomeric, cytosolic protein primarily responsible for shuttling phosphatidylinositol, phosphatidylcholine, and sphingomyelin between membrane compartments, facilitating their availability for signaling and biosynthetic processes[1][2][3][4][6]. PITPNB is essential for the biosynthesis of polyphosphoinositides and thus crucial for cell signaling pathways—including those involved in platelet activation and tumor metastasis—by acting both as a lipid transporter and as a cofactor that presents lipids to specific kinases[2]. It plays a nonredundant role alongside its paralog PITPNA (alpha isoform), and while both isoforms can compensate partially for one another, each has unique contributions to membrane dynamics and cellular function[2]. PITPNB is expressed ubiquitously in human tissues and is linked to several disease states, with research ongoing to clarify its broader therapeutic significance[1][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylinositol transfer protein beta (PITPNB).